The initiative for a global cancer classification began in following a World Health Assembly resolution. For decades, head and neck tumors were fragmented across several smaller volumes—covering oral, respiratory tract, salivary gland, and odontogenic tumors—until they were unified into comprehensive editions to better reflect the interdisciplinary nature of the field. This unification allows clinicians and researchers to use a shared taxonomic language (site, category, family, and subtype) for more accurate communication. Key Updates in the 5th Edition

The , currently in its 5th edition (2024) , serves as the definitive international "gold standard" for the diagnosis, nomenclature, and clinical management of neoplastic diseases in the head and neck region. Part of the renowned "WHO Blue Books" series, this classification provides a unique synthesis of histopathological diagnosis with emerging digital and molecular pathology to ensure standardized care and research across the globe. Historical Context and Significance

The latest edition reflects rapid advancements in genomics and molecular markers, moving beyond traditional histopathology to more objective diagnostic criteria. Notable changes include: Head and Neck Tumours - IARC Publications